Skip to main content
Erschienen in: Pediatric Radiology 6/2019

01.05.2019 | Commentary

American College of Radiology LI-RADS in pediatric patients: the good, the bad, and the future

verfasst von: Gary R. Schooler

Erschienen in: Pediatric Radiology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Excerpt

“Children are not little adults” is a phrase often used in pediatric medicine. One area where this sentiment is particularly true is in the evaluation and management of pediatric focal liver lesions. In this issue of Pediatric Radiology, Ludwig et al. [1] reported on their experience with applying the American College of Radiology (ACR) Liver Imaging Reporting and Data System (LI-RADS) v2017 in pediatric patients. The authors retrospectively evaluated the application of the LI-RADS v2017 criteria to a cohort of pediatric patients with known liver lesions [1]. In light of this paper and ongoing efforts to standardize the imaging evaluation of pediatric hepatocellular carcinoma (HCC) and hepatoblastoma, I would like to share my thoughts on the potential benefits and drawbacks of using the current version of LI-RADS in the pediatric population and where our efforts as pediatric liver imagers might lead us. …
Literatur
1.
Zurück zum Zitat Ludwig DR, Romberg EK, Fraum TJ et al (2019) Diagnostic performance of liver imaging reporting and data system (LI-RADS) v2017 in predicting malignant liver lesions in pediatric patients: a preliminary study. Pediatr Radiol Ludwig DR, Romberg EK, Fraum TJ et al (2019) Diagnostic performance of liver imaging reporting and data system (LI-RADS) v2017 in predicting malignant liver lesions in pediatric patients: a preliminary study. Pediatr Radiol
3.
Zurück zum Zitat Czauderna P, Lopez-Terranda D, Hiyama E et al (2014) Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 26:19–28CrossRefPubMed Czauderna P, Lopez-Terranda D, Hiyama E et al (2014) Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 26:19–28CrossRefPubMed
4.
Zurück zum Zitat Shuman C, Beckwith JB, Weksberg R (1993) Beckwith-Wiedemann syndrome. GreenReviews, Seattle Shuman C, Beckwith JB, Weksberg R (1993) Beckwith-Wiedemann syndrome. GreenReviews, Seattle
5.
Zurück zum Zitat Spector LG, Brich J (2012) The epidemiology of hepatoblastoma. Pediatr Blood Cancer 59:776–779CrossRefPubMed Spector LG, Brich J (2012) The epidemiology of hepatoblastoma. Pediatr Blood Cancer 59:776–779CrossRefPubMed
6.
Zurück zum Zitat Trobaugh-Lotrario AD, Lopez-Terrada D, Li P et al (2018) Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: clinical characteristics and rationale for surveillance screening. Pediatr Blood Cancer 65:e27103CrossRefPubMed Trobaugh-Lotrario AD, Lopez-Terrada D, Li P et al (2018) Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: clinical characteristics and rationale for surveillance screening. Pediatr Blood Cancer 65:e27103CrossRefPubMed
7.
Zurück zum Zitat Chung EM, Lattin GE Jr, Cube R et al (2011) From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors. Radiographics 31:483–507CrossRefPubMed Chung EM, Lattin GE Jr, Cube R et al (2011) From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors. Radiographics 31:483–507CrossRefPubMed
8.
Zurück zum Zitat Czauderna P, Mackinlay G, Perilongo G et al (2002) Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology Group. J Clin Oncol 20:2798–2804CrossRefPubMed Czauderna P, Mackinlay G, Perilongo G et al (2002) Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology Group. J Clin Oncol 20:2798–2804CrossRefPubMed
10.
Zurück zum Zitat Lau CS, Mahendraraj K, Chamberlain RS (2015) Hepatocellular carcinoma in the pediatric population: a population based clinical outcomes study involving 257 patients from the surveillance, epidemiology, and end result (SEER) database (1973-2011). HPB Surg 2015:670728 Lau CS, Mahendraraj K, Chamberlain RS (2015) Hepatocellular carcinoma in the pediatric population: a population based clinical outcomes study involving 257 patients from the surveillance, epidemiology, and end result (SEER) database (1973-2011). HPB Surg 2015:670728
11.
Zurück zum Zitat Schmid I, von Schweintz D (2017) Pediatric hepatocellular carcinoma: challenges and solutions. J Hepatocell Carcinoma 4:15–21 Schmid I, von Schweintz D (2017) Pediatric hepatocellular carcinoma: challenges and solutions. J Hepatocell Carcinoma 4:15–21
Metadaten
Titel
American College of Radiology LI-RADS in pediatric patients: the good, the bad, and the future
verfasst von
Gary R. Schooler
Publikationsdatum
01.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 6/2019
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-019-04351-2

Weitere Artikel der Ausgabe 6/2019

Pediatric Radiology 6/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.